Evotec SE (ETR:EVT – Get Free Report) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of €7.59 ($8.16) and traded as low as €7.10 ($7.63). Evotec shares last traded at €7.12 ($7.65), with a volume of 2,952,098 shares trading hands.
Evotec Stock Performance
The company’s fifty day simple moving average is €8.35 and its two-hundred day simple moving average is €7.59. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of -7.70, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
See Also
- Five stocks we like better than Evotec
- The How And Why of Investing in Oil Stocks
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- 3 Stocks to Consider Buying in October
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Market Cap Calculator: How to Calculate Market Cap
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
